Prominent Medical Device Company Celebrating 50th Anniversary with Increased R&D Investment and
Attendance at Heart Rhythm 2011 Conference
MINNEAPOLIS — April 29, 2011—Lake Region Medical (LRM), celebrating its 50th year in the cardiac rhythm
management market, will spend an all‐time high investment—nearly 10% of its annual sales— in research and
development. To demonstrate this increased commitment to research and development partnerships with
MedTech companies, LRM will make its first appearance at the annual Heart Rhythm Society meeting, Heart
Rhythm 2011, the Heart Rhythm Society's 32nd Annual Scientific Sessions, in San Francisco May 4‐11.
The R&D capital increase will directly support the development of customer non‐core technologies with special
attention towards developing interventional accessories for delivery of minimally invasive therapies. LRM's
knowledge of the clinical and regulatory requirements globally, combined with its experience working with the
sophisticated quality and regulatory systems within its customer's organizations for the past 50 years, facilitate its
ability to innovate with its industry partners.
Due to impending and unknowable tax impacts from the new U.S. Healthcare bill, Original Equipment
Manufacturers (OEMs) have begun to more closely scrutinize non‐core research and design budgets. According to
Jim Mellor, Lake Region Vice President of Sales and Marketing, the current R&D constraints on MedTech
companies and declining investment in start‐ups have shifted LRM's primary model from being a major
manufacturer to being an Original Development Manufacturer for its existing customers.
"After five decades, LRM increasingly finds itself in the business of delivering health outcomes," Mellor says.
"OEMs must prove that their products work in a highly regulated environment. With the added investment,
combined with our industry experience, not only are we positioned to enable our customers to stay innovative by
providing critical R&D support, but through our longevity and support of a large number of OEMs and devices we
have become adept at navigating the complicated regulatory environment."
Joe Fleischhacker, the CEO of Lake Region Medical, acknowledged that the company's inaugural attendance at this
year's Heart Rhythm Society (HRS) event, Heart Rhythm 2011, allows the company to maintain and expand its
pulse on the industry. "To utilize our expanded research and design capabilities to their fullest extent, we need to
maintain a clear understanding of future developments within our customers, as well as emerging clinical
procedures in the field."
"Our formal participation at this world‐renowned gathering of electrophysiologists, physicians, and scientists
reflects LRM's renewed commitment to the cardiac rhythm management market," Fleischhacker notes. "We look
forward to discussing the new advances being made in the research and delivery of arrhythmia care, sharing the
expertise we've acquired over the past fifty years, and discussing how our increased investment can benefit our
Mark Christensen, Cardiac Rhythm Management (CRM) Marketing Manager at LRM, added that the increased R&D
investment furthers LRM's strategic focus on developing advanced delivery platforms, new coatings, and more
efficient processes in order to provide finished products and components that provide competitive advantages.
"Our participation at Heart Rhythm 2011, backed by our expanded R&D initiatives, places LRM at the forefront of
emerging medical therapies," stated Christensen. "We are committed to advancing technologies central to the
delivery systems that enable access to and precise therapy placement in the heart to facilitate cardiac rhythm